Factors associated with mortality in transplant patients with invasive aspergillosis.
Factors associated with mortality in transplant patients with invasive aspergillosis.
复制标题
DOI:
10.1086/652768
复制
发表时间:
2010-06-15
期刊:
影响因子:
--
通讯作者:
Pappas PG
中科院分区:
文献类型:
--
作者:
Baddley JW;Andes DR;Marr KA;Kontoyiannis DP;Alexander BD;Kauffman CA;Oster RA;Anaissie EJ;Walsh TJ;Schuster MG;Wingard JR;Patterson TF;Ito JI;Williams OD;Chiller T;Pappas PG
Invasive aspergillosis (IA) is an important cause of morbidity and mortality in hematopoietic stem cell (HSCT) and solid organ transplant (SOT) recipients. The purpose of this study was to evaluate factors associated with mortality in transplant patients with IA. Transplant patients from 23 U.S. centers were enrolled from March 2001 to October 2005 as part of the Transplant Associated Infection Surveillance Network (TRANSNET). IA cases were identified prospectively in this cohort through March 2006, and data were collected. Factors associated with 12-week all-cause mortality were determined by logistic regression analysis and Cox proportional hazards regression. Six-hundred forty-two cases of proven or probable IA were evaluated, of which 317 (49.4%) died by the study endpoint. All-cause mortality was greater in HSCT (239/415, 57.5%) when compared to SOT patients (78/227, 34.4%; p<0.001). Independent poor prognostic factors in HSCT patients were neutropenia, renal insufficiency, hepatic insufficiency, early-onset IA, proven IA and methylprednisolone use. In contrast, white race was associated with decreased risk of death. Among SOT patients, hepatic insufficiency, malnutrition and CNS disease were poor prognostic indicators; whereas, prednisone use was associated with decreased risk of death. Among HSCT or SOT patients who received antifungal therapy, use of an amphotericin B preparation as part of initial therapy was associated with increased risk of death. There are multiple variables associated with survival in transplant patients with IA. Understanding these prognostic factors may assist in the development of treatment algorithms and clinical trials.
登录
查看更多内容
影响因子:
11.8
作者:
Walsh, Thomas J.;Raad, Issam;Perfect, John R.
通讯作者:
Perfect, John R.
影响因子:
11.8
作者:
Ascioglu, S;Rex, JH;Walsh, TJ
通讯作者:
Walsh, TJ
影响因子:
11.8
作者:
Ribaud, P;Chastang, C;Gluckman, E
通讯作者:
Gluckman, E
影响因子:
11.8
作者:
Upton, Arlo;Kirby, Katharine A.;Marr, Kieren A.
通讯作者:
Marr, Kieren A.
DOI:
10.1086/590566
发表时间:
2008-09-01
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Segal BH;Herbrecht R;Stevens DA;Ostrosky-Zeichner L;Sobel J;Viscoli C;Walsh TJ;Maertens J;Patterson TF;Perfect JR;Dupont B;Wingard JR;Calandra T;Kauffman CA;Graybill JR;Baden LR;Pappas PG;Bennett JE;Kontoyiannis DP;Cordonnier C;Viviani MA;Bille J;Almyroudis NG;Wheat LJ;Graninger W;Bow EJ;Holland SM;Kullberg BJ;Dismukes WE;De Pauw BE
通讯作者:
De Pauw BE